Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Signal transduction and targeted therapy 2023-02, Vol.8 (1), p.60-60, Article 60
Hauptverfasser:	Pang, Xiaocong, Sun, Xiaojiao, Gu, Yanlun, He, Xu, Gong, Kan, Song, Song, Zhang, Jixin, Xia, Jie, Liu, Zhenming, Cui, Yimin
Format:	Artikel
Sprache:	eng
Schlagworte:	631/154/1435 692/4028/67/1059/153 Benzamides - pharmacology Cancer Research Castration Cell Biology Humans Internal Medicine Letter Male Medicine Medicine & Public Health Nitriles Oncology Pathology Phenylthiohydantoin - pharmacology Phenylthiohydantoin - therapeutic use Prostate cancer Prostatic Neoplasms, Castration-Resistant - drug therapy Prostatic Neoplasms, Castration-Resistant - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!